Date & Location
Wednesday, June 8, 2022, 12:00 AM - Thursday, June 8, 2023, 12:00 PM

Overview

This online lecture provides physicians and other healthcare practitioners updates on current issues related to healthcare. The lecture will be maximum of one hour in length, followed by post test. Participants will have the opportunity to learn about most current evidence based guidelines regarding screening mammography, BIRADS classification system, major types of abnormalities & recent advances in imaging

Release date: June 8, 2022

End Date: June 8, 2023


Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Researchers, Students

Overall Learning Objective
  1. 1. Define the most current evidence based guidelines regarding screening mammography
  2. 2. Define BIRADS classification system as it pertains to breast imaging
  3. 3. List the major types of abnormalities that can be detected
  4. 4. Outline some recent advances in breast imaging

Registration
FREE of charge

Accreditation

The Ministry of Public Health's Department of Healthcare Professions (DHP) considers Asynchronous activities under Category 2 as self-directed learning.  

 

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Bibliography

1. Effect of mammographic screening from age 40 years on breast cancer mortality
(UK Age trial): final results of a randomized, controlled trial The Lancet Oncology, ISSN:
1470-2045, Vol: 21, Issue: 9, Page: 1165-1172. 2020 

2. https://www.nhs.uk/conditions/breast-screening-mammogram/when-youll-be-invited-and-who-should-go/ 

3. https://www.moph.gov.qa/english/derpartments/healthaffairs/healthpromotion/nationalcancerprogram/cancerscreening/Pages/default.aspx#:~:text=Breast%20Cancer%20Screening,-The%20program%20provides&text=To%20invite%20all%20women%20aged,in%20the%20State%20of%20Qatar

4. https://acsearch.acr.org/docs/70910/Narrative/

5. Differences in breast cancer incidence among young women aged 20-49 years by stage
and tumor characteristics, age, race, and ethnicity, 2004-2013. Breast Cancer Res Treat.
2018 Jun;169(3):595-606. doi: 10.1007/s10549-018-4699-9. Epub 2018 Feb 14. PMID:
29445940; PMCID: PMC5955792.

6. Global incidence and mortality of breast cancer: a trend analysis. Aging vol. 13,4 (2021):
5748-5803. doi:10.18632/aging.202502

7. Breast Cancer Detection in Qatar: Evaluation of Mammography Image Quality Using A
Standardized Assessment Tool. European journal of breast health vol. 16,2 124-128. 1
Apr. 2020, doi:10.5152/ejbh.2020.5115

8. https://emedicine.medscape.com/article/1945957-overview

9. https://www.breastcancer.org/risk/risk-factors/breastfeeding-history

10. https://www.cancer.org/treatment/understanding-your-diagnosis/tests/understanding-radiation-risk-from-imaging-tests

11. https://acsearch.acr.org/docs/70910/Narrative/